A drug used to treat multiple sclerosis (MS), alemtuzumab, was found to reverse some of the physical disability caused by the disease. Because it can cause serious side effects, alemtuzumab is generally used in people who have not responded well to other MS drugs; however, in this study, it was used relatively early in the course of MS. The drug issued in relapsing-remitting MS, the most common form o the disease, in which symptoms alternate between sudden worsening and remission. “While many MS drugs slow the progress of disability, there have been little data about the ability of current treatments to help restore function previously lost to MS,” said study author Gavin Giovannoni, MD, PhD, of Queen Mary University of London. Click here to read more.
